Volume | 3,990,792 |
|
|||||
News | - | ||||||
Day High | 0.00015 | Low High |
|||||
Day Low | 0.0001 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Nutra Pharma Corp (PK) | NPHC | OTCMarkets | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
0.00015 | 0.0001 | 0.00015 | 0.0001 | 0.0001 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
3 | 3,990,792 | $ 0.0001 | $ 400 | - | 0.000001 - 0.0017 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
11:31:14 | 3,848,474 | $ 0.0001 | USD |
Nutra Pharma Corp (PK) Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
$ 703.97k | 7.04B | 1.47B | $ - | $ - | - | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
4.97k | $ - | - | - | - |
Nutra Pharma (PK) News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NPHC Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.0001 | 0.00015 | 0.0001 | 0.0001 | 118,117 | 0.00 | 0.0% |
1 Month | 0.00001 | 0.00015 | 0.000001 | 0.0001021 | 221,971 | 0.00009 | 900.0% |
3 Months | 0.0001 | 0.00015 | 0.000001 | 0.0000859 | 296,818 | 0.00 | 0.0% |
6 Months | 0.0003 | 0.0005 | 0.000001 | 0.0001567 | 484,391 | -0.0002 | -66.67% |
1 Year | 0.0008 | 0.0017 | 0.000001 | 0.0004592 | 522,492 | -0.0007 | -87.5% |
3 Years | 0.00059 | 0.0158 | 0.000001 | 0.0033248 | 13,681,584 | -0.00049 | -83.05% |
5 Years | 0.0015 | 0.0158 | 0.000001 | 0.002477 | 11,625,311 | -0.0014 | -93.33% |
Nutra Pharma (PK) Description
Nutra Pharma Corporation operates as a biotechnology company specializing in the acquisition, licensing, and commercialization of pharmaceutical products and technologies for the management of neurological disorders, cancer, autoimmune, and infectious diseases, including Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain. Additionally, the Company markets drug products for sale for the treatment of pain under the brands Nyloxin, Pet Pain-Away, Equine Pain-Away and Luxury Feet.. |